Nabriva Therapeutics plc reports

Location
25 28 North Wall Quay, Dublin, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Data updated at
7/30/2024, 05:08 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Oct 19, 2023 Jun 30, 2023
8-K Report | Data FORM 8-K Jul 31, 2023 Jul 30, 2023
8-K Report | Data FORM 8-K Jul 24, 2023 Jul 21, 2023
8-K Report | Data FORM 8-K Jul 7, 2023 Jun 30, 2023
8-K Report | Data FORM 8-K Jun 1, 2023 May 25, 2023
10-Q Report | Data 10-Q May 22, 2023 Mar 31, 2023
10-K Report | Data 10-K Apr 17, 2023 Dec 31, 2022
8-K Report | Data FORM 8-K Feb 6, 2023 Jan 31, 2023
8-K Report | Data FORM 8-K Jan 20, 2023 Jan 15, 2023
8-K Report | Data FORM 8-K Jan 9, 2023 Jan 4, 2023
8-K Report | Data FORM 8-K Nov 28, 2022 Nov 28, 2022
8-K Report | Data 8-K Nov 10, 2022 Nov 10, 2022
10-Q Report | Data 10-Q Nov 10, 2022 Sep 30, 2022
8-K Report | Data FORM 8-K Oct 4, 2022 Sep 30, 2022
8-K Report | Data FORM 8-K Sep 16, 2022 Sep 15, 2022
8-K Report | Data FORM 8-K Aug 17, 2022 Aug 11, 2022
8-K Report | Data FORM 8-K Aug 11, 2022 Aug 11, 2022
10-Q Report | Data 10-Q Aug 3, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 3, 2022 Aug 3, 2022
8-K Report | Data FORM 8-K Jul 6, 2022 Jul 6, 2022
10-Q Report | Data 10-Q May 5, 2022 Mar 31, 2022
8-K Report | Data 8-K May 5, 2022 May 5, 2022
10-K Report | Data 10-K Mar 29, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 29, 2022 Mar 29, 2022
8-K Report | Data FORM 8-K Mar 24, 2022 Mar 24, 2022
SC 13G/A Report Feb 9, 2022
8-K Report | Data FORM 8-K Feb 2, 2022 Jan 28, 2022
8-K Report | Data FORM 8-K Jan 18, 2022 Jan 18, 2022
8-K Report | Data FORM 8-K Jan 14, 2022 Jan 14, 2022
8-K Report | Data FORM 8-K Jan 10, 2022 Jan 10, 2022
8-K Report | Data FORM 8-K Jan 7, 2022 Jan 4, 2022
8-K Report | Data FORM 8-K Dec 22, 2021 Dec 22, 2021
SC 13G Report SC 13G Nov 19, 2021
10-Q Report | Data 10-Q Nov 9, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 9, 2021 Nov 9, 2021
8-K Report | Data FORM 8-K Sep 27, 2021 Sep 24, 2021
10-Q Report | Data 10-Q Aug 5, 2021 Jun 30, 2021
8-K Report | Data 8-K Aug 5, 2021 Aug 5, 2021
8-K Report | Data FORM 8-K Jul 30, 2021 Jul 28, 2021
8-K Report | Data FORM 8-K Jun 3, 2021 Jun 1, 2021
8-K Report | Data FORM 8-K May 25, 2021 May 25, 2021
10-Q Report | Data 10-Q May 6, 2021 Mar 31, 2021
8-K Report | Data 8-K May 6, 2021 May 6, 2021
8-K Report | Data FORM 8-K Apr 15, 2021 Apr 15, 2021
10-K Report | Data 10-K Mar 11, 2021 Dec 31, 2020
8-K Report | Data 8-K Mar 11, 2021 Mar 11, 2021
8-K Report | Data FORM 8-K Mar 1, 2021 Mar 1, 2021
8-K Report | Data FORM 8-K Feb 26, 2021 Feb 24, 2021
8-K Report | Data FORM 8-K Feb 12, 2021 Feb 8, 2021
SC 13G/A Report Feb 8, 2021
8-K Report | Data FORM 8-K Feb 1, 2021 Feb 1, 2021
8-K Report | Data FORM 8-K Dec 14, 2020 Dec 10, 2020
8-K Report | Data FORM 8-K Dec 7, 2020 Dec 7, 2020
8-K Report | Data FORM 8-K Dec 3, 2020 Dec 2, 2020
10-Q Report | Data 10-Q Nov 5, 2020 Sep 30, 2020
8-K Report | Data 8-K Nov 5, 2020 Nov 5, 2020
8-K Report | Data FORM 8-K Sep 1, 2020 Sep 1, 2020
10-Q Report | Data 10-Q Aug 6, 2020 Jun 30, 2020
8-K Report | Data 8-K Aug 6, 2020 Aug 6, 2020
8-K Report | Data FORM 8-K Jul 29, 2020 Jul 29, 2020
8-K Report | Data FORM 8-K Jul 15, 2020 Jul 15, 2020
8-K Report FORM 8-K Jun 22, 2020 Jun 19, 2020
8-K Report FORM 8-K Jun 1, 2020 May 29, 2020
8-K Report FORM 8-K May 29, 2020 May 29, 2020
8-K Report FORM 8-K May 27, 2020 May 26, 2020
10-Q Report | Data 10-Q May 11, 2020 Mar 31, 2020
8-K Report FORM 8-K May 11, 2020 May 11, 2020
8-K Report FORM 8-K May 1, 2020 Apr 29, 2020
8-K Report FORM 8-K Apr 7, 2020 Apr 7, 2020
10-K Report | Data 10-K Mar 12, 2020 Dec 31, 2019
8-K Report FORM-8K Mar 12, 2020 Mar 12, 2020
SC 13G/A Report SC 13G/A Feb 12, 2020
8-K Report FORM 8-K Feb 12, 2020 Feb 6, 2020
SC 13G Report Feb 7, 2020
8-K Report FORM 8-K Jan 8, 2020 Jan 8, 2020
SC 13D/A Report AMENDMENT NO. 4 Dec 26, 2019
8-K Report FORM 8-K Dec 23, 2019 Dec 20, 2019
8-K Report FORM 8-K Dec 20, 2019 Dec 20, 2019
8-K Report FORM 8-K Dec 20, 2019 Dec 20, 2019
SC 13D/A Report AMENDMENT NO. 3 Dec 6, 2019
10-Q Report | Data 10-Q Nov 12, 2019 Sep 30, 2019
8-K Report 8-K Nov 12, 2019 Nov 12, 2019
8-K Report 8-K Sep 26, 2019 Sep 20, 2019
8-K Report 8-K Sep 9, 2019 Sep 6, 2019
8-K Report 8-K Aug 19, 2019 Aug 16, 2019
SC 13G/A Report SC 13G/A Aug 14, 2019
10-Q Report | Data 10-Q Aug 8, 2019 Jun 30, 2019
8-K Report 8-K Aug 8, 2019 Aug 8, 2019
8-K Report 8-K Aug 5, 2019 Jul 31, 2019
8-K Report 8-K Jul 25, 2019 Jul 25, 2019
SC 13G/A Report SC 13G/A Jul 1, 2019
8-K Report 8-K Jun 25, 2019 Jun 24, 2019
8-K Report 8-K Jun 20, 2019 Jun 20, 2019
10-Q Report | Data 10-Q May 10, 2019 Mar 31, 2019
8-K Report 8-K May 10, 2019 May 10, 2019
8-K Report 8-K May 1, 2019 Apr 30, 2019
8-K Report 8-K Apr 1, 2019 Mar 28, 2019
10-K Report | Data 10-K Mar 12, 2019 Dec 31, 2018
8-K Report 8-K Mar 12, 2019 Mar 12, 2019
8-K Report 8-K Feb 19, 2019 Feb 19, 2019
SC 13G/A Report SC 13G/A Feb 14, 2019
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2019
SC 13G/A Report SC 13G/A Feb 14, 2019
SC 13G/A Report VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13G/A Feb 14, 2019
SC 13G/A Report SEC SCHEDULE 13G Feb 11, 2019
SC 13G/A Report SEC SCHEDULE 13G Feb 8, 2019
SC 13G/A Report SC 13G/A Feb 1, 2019
8-K Report 8-K Jan 14, 2019 Jan 14, 2019
8-K Report 8-K Jan 4, 2019 Jan 4, 2019
8-K Report 8-K Dec 21, 2018 Dec 20, 2018
10-Q Report | Data 10-Q Nov 6, 2018 Sep 30, 2018
8-K Report 8-K Nov 6, 2018 Nov 6, 2018
8-K Report 8-K Oct 31, 2018 Oct 31, 2018
8-K/A Report 8-K/A Sep 10, 2018 Jul 23, 2018
SC 13G/A Report SEC SCHEDULE 13G Aug 10, 2018
10-Q Report | Data 10-Q Aug 9, 2018 Jun 30, 2018
8-K Report 8-K Aug 9, 2018 Aug 9, 2018
SC 13G Report SC 13G Aug 7, 2018
8-K Report 8-K Aug 7, 2018 Aug 1, 2018
SC 13G/A Report SC 13G/A Aug 6, 2018
SC 13G Report SC 13G Aug 3, 2018
8-K Report 8-K Aug 1, 2018 Jul 26, 2018
8-K Report 8-K Jul 25, 2018 Jul 23, 2018
8-K Report 8-K Jun 19, 2018 Jun 13, 2018
8-K Report 8-K May 21, 2018 May 21, 2018
10-Q Report | Data 10-Q May 8, 2018 Mar 31, 2018
8-K Report 8-K Apr 20, 2018 Apr 20, 2018
SC 13G Report SEC SCHEDULE 13G Apr 10, 2018
8-K Report 8-K Mar 27, 2018 Mar 26, 2018
8-K Report 8-K Mar 16, 2018 Mar 16, 2018
10-K Report | Data 10-K Mar 16, 2018 Dec 31, 2017
8-K Report 8-K Mar 16, 2018 Mar 16, 2018
8-K Report 8-K Feb 21, 2018 Feb 21, 2018
SC 13G/A Report SC 13G/A Feb 12, 2018
SC 13G/A Report VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13GA Feb 9, 2018
SC 13G/A Report SC 13G/A Feb 5, 2018
8-K Report 8-K Feb 2, 2018 Jan 31, 2018
SC 13G/A Report SC 13G/A Feb 2, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
10-Q Report | Data 10-Q Nov 9, 2017 Sep 30, 2017
8-K Report 8-K Nov 9, 2017 Nov 9, 2017
8-K Report 8-K Nov 7, 2017 Nov 7, 2017
SC 13G/A Report SC 13G/A Oct 10, 2017
8-K Report 8-K Sep 20, 2017 Sep 19, 2017
8-K Report 8-K Sep 18, 2017 Sep 18, 2017
8-K Report 8-K Sep 15, 2017 Sep 15, 2017
8-K Report 8-K Aug 31, 2017 Aug 31, 2017
8-K Report 8-K Aug 21, 2017 Aug 17, 2017
8-K Report 8-K Aug 11, 2017 Aug 9, 2017
8-K Report 8-K Aug 7, 2017 Aug 7, 2017
10-Q Report | Data 10-Q Aug 7, 2017 Jun 30, 2017
8-K Report 8-K Jul 21, 2017 Jun 23, 2017
SC 13G/A Report SEC SCHEDULE 13G Jul 10, 2017
8-K Report 8-K Jun 19, 2017 Jun 19, 2017
8-K Report 8-K Jun 9, 2017 Jun 8, 2017
8-K Report 8-K May 31, 2017 May 24, 2017
8-K Report 8-K May 23, 2017 May 23, 2017
8-K/A Report 8-K/A May 12, 2017 May 10, 2017
8-K Report 8-K May 10, 2017 May 10, 2017
10-Q Report | Data 10-Q May 10, 2017 Mar 31, 2017
8-K Report 8-K Apr 18, 2017 Apr 17, 2017
8-K Report 8-K Apr 5, 2017 Apr 5, 2017
10-K Report | Data 10-K Mar 24, 2017 Dec 31, 2016
8-K Report 8-K Mar 24, 2017 Mar 24, 2017
8-K Report 8-K Feb 15, 2017 Feb 15, 2017
SC 13G/A Report SC 13G/A Feb 13, 2017
8-K Report 8-K Feb 13, 2017 Feb 7, 2017
SC 13G/A Report NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #1) Feb 13, 2017
SC 13G/A Report PHASE4 PARTNERS LTD SC 13GA 12-31-2016 (NABRIVA THERAPEUTICS AG) Feb 10, 2017
SC 13G Report SEC SCHEDULE 13G Feb 9, 2017
SC 13G/A Report SC 13G/A Feb 8, 2017
8-K Report 8-K Jan 9, 2017 Jan 3, 2017
6-K Report 6-K Dec 20, 2016 Dec 19, 2016
6-K Report 6-K Dec 15, 2016 Dec 15, 2016
6-K Report 6-K Nov 29, 2016 Nov 29, 2016
6-K Report 6-K Nov 29, 2016 Nov 29, 2016
6-K Report 6-K Nov 22, 2016 Nov 22, 2016
6-K Report 6-K Nov 16, 2016 Nov 16, 2016
6-K Report 6-K Nov 14, 2016 Nov 14, 2016
6-K Report 6-K Oct 21, 2016 Oct 21, 2016
6-K Report 6-K Oct 17, 2016 Oct 17, 2016
6-K Report 6-K Aug 29, 2016 Aug 29, 2016
6-K Report 6-K Aug 9, 2016 Aug 9, 2016
SC 13G Report SC 13G Jul 29, 2016
6-K Report 6-K Jul 25, 2016 Jul 25, 2016
SC 13G/A Report SCHEDULE 13G/A FOR NABRIVA THERAPEUTICS AG BY THE WELLCOME TRUST LIMITED May 10, 2016
6-K Report | Data 6-K May 10, 2016 May 10, 2016
6-K Report | Data 6-K May 2, 2016 May 2, 2016
SC 13G Report Apr 29, 2016
20-F Report 20-F Apr 28, 2016 Dec 31, 2015
6-K Report | Data 6-K Apr 27, 2016 Apr 27, 2016
6-K Report | Data 6-K Apr 12, 2016 Apr 12, 2016
6-K Report 6-K Apr 8, 2016 Apr 8, 2016
SC 13G Report SEC SCHEDULE 13G Mar 23, 2016
SC 13G Report SCHEDULE 13G Feb 12, 2016
SC 13G Report PHASE4 PARTNERS LTD SC 13G 9-23-2015 (NABRIVA THERAPEUTICS) Feb 12, 2016
6-K Report 6-K Jan 11, 2016 Jan 11, 2016
6-K Report 6-K Dec 30, 2015 Dec 30, 2015
6-K Report 6-K Nov 10, 2015 Nov 11, 2015
SC 13G Report SC 13G Oct 5, 2015
SC 13D Report SCHEDULE 13D Oct 2, 2015
6-K Report FORM 6-K Sep 30, 2015 Sep 30, 2015
SC 13G Report SCHEDULE 13G Sep 29, 2015
SC 13G Report SCHEDULE 13G Sep 25, 2015